CN103735503B - 一种硫氰酸红霉素乳剂及其制备方法 - Google Patents
一种硫氰酸红霉素乳剂及其制备方法 Download PDFInfo
- Publication number
- CN103735503B CN103735503B CN201310647703.9A CN201310647703A CN103735503B CN 103735503 B CN103735503 B CN 103735503B CN 201310647703 A CN201310647703 A CN 201310647703A CN 103735503 B CN103735503 B CN 103735503B
- Authority
- CN
- China
- Prior art keywords
- erythromycin thiocyanate
- emulsion
- liquid
- changed
- milliliters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PGNYNCTUBKSHHL-UHFFFAOYSA-N 2,3-diaminobutanedioic acid Chemical compound OC(=O)C(N)C(N)C(O)=O PGNYNCTUBKSHHL-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 239000000839 emulsion Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims description 15
- 238000004945 emulsification Methods 0.000 title description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 12
- 229920001525 carrageenan Polymers 0.000 claims abstract description 12
- 239000006184 cosolvent Substances 0.000 claims abstract description 11
- 239000002270 dispersing agent Substances 0.000 claims abstract description 11
- 239000000679 carrageenan Substances 0.000 claims abstract description 8
- 229940113118 carrageenan Drugs 0.000 claims abstract description 8
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 45
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- 239000008213 purified water Substances 0.000 claims description 21
- 238000010438 heat treatment Methods 0.000 claims description 18
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 8
- 239000002562 thickening agent Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 239000000178 monomer Substances 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 4
- 238000001514 detection method Methods 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 238000001556 precipitation Methods 0.000 abstract description 3
- 230000008719 thickening Effects 0.000 abstract description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 244000144977 poultry Species 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000018569 Respiratory Tract disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 1
- 241000755266 Kathetostoma giganteum Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310647703.9A CN103735503B (zh) | 2013-12-06 | 2013-12-06 | 一种硫氰酸红霉素乳剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310647703.9A CN103735503B (zh) | 2013-12-06 | 2013-12-06 | 一种硫氰酸红霉素乳剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103735503A CN103735503A (zh) | 2014-04-23 |
CN103735503B true CN103735503B (zh) | 2016-06-08 |
Family
ID=50492624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310647703.9A Active CN103735503B (zh) | 2013-12-06 | 2013-12-06 | 一种硫氰酸红霉素乳剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103735503B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2791531A (en) * | 1953-10-22 | 1957-05-07 | Lilly Co Eli | Erythromycin thiocyanate and compositions containing same |
CN101032507A (zh) * | 2007-04-06 | 2007-09-12 | 西北农林科技大学 | 一种红霉素纳米乳抗菌药物及其制备方法 |
CN102659880A (zh) * | 2011-04-21 | 2012-09-12 | 胡梨芳 | 琥乙红霉素结晶水合物及其制备和用途 |
-
2013
- 2013-12-06 CN CN201310647703.9A patent/CN103735503B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2791531A (en) * | 1953-10-22 | 1957-05-07 | Lilly Co Eli | Erythromycin thiocyanate and compositions containing same |
CN101032507A (zh) * | 2007-04-06 | 2007-09-12 | 西北农林科技大学 | 一种红霉素纳米乳抗菌药物及其制备方法 |
CN102659880A (zh) * | 2011-04-21 | 2012-09-12 | 胡梨芳 | 琥乙红霉素结晶水合物及其制备和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN103735503A (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101810569B (zh) | 一种恩诺沙星注射液及其制备方法 | |
CN102205126A (zh) | 儿茶素类物质联合后与抗菌药物的联合的应用 | |
CN103479574A (zh) | 一种用于防治干奶期奶牛***炎的***注入剂及其制备方法 | |
CN103735503B (zh) | 一种硫氰酸红霉素乳剂及其制备方法 | |
CN106727618B (zh) | 复方磺胺甲噁唑口服混悬剂及其制备方法 | |
CN102600304A (zh) | 一种用于畜禽支原体肺炎治疗的纳米乳组合物及其制备方法 | |
CN101874774A (zh) | 一种含有溶菌酶和氟苯尼考的混悬剂组合物及其制备方法 | |
CN104382898A (zh) | 一种复方阿莫西林***注入剂及其制备方法 | |
CN104027370B (zh) | 一种含有白花丹和痢菌净的畜禽用复方组合物 | |
CN103385804A (zh) | 防治口腔疾病的纳米银漱口水及其制备方法 | |
CN103690965A (zh) | 一种猫自主采食型药物载体及其制备方法 | |
CN104161761A (zh) | 一种复方土霉素注射液及其制备方法 | |
CN107875154B (zh) | 含有哌拉西林的组合物、其药物制剂及其应用 | |
CN102499935B (zh) | 一种复方螺旋霉素纳米乳口服液及其制备方法 | |
CN104622803A (zh) | 一种治疗泌乳期奶牛***炎的***注入剂及制备方法 | |
CN105878179A (zh) | 一种氟苯尼考溶液制备方法及应用 | |
CN101810666B (zh) | 兽用增效恩诺沙星注射液及其制备方法 | |
CN103933085B (zh) | 穿心莲和磷霉素在制备治疗畜禽大肠杆菌感染疾病的复方药物中的应用 | |
CN103720645A (zh) | 一种硫氰酸红霉素注射液及其制备方法 | |
RU2524664C1 (ru) | Способ профилактики массовых желудочно-кишечных и респираторных болезней молочных поросят | |
CN106727720A (zh) | 一种用于牛***炎的药物及其制备方法 | |
CN102000100A (zh) | 一种抗球虫的纳米混悬剂及其配制方法 | |
CN105497047B (zh) | 复方硫酸庆大‑小诺霉素注射液及其制备方法 | |
CN103977028A (zh) | 甘薯叶绿原酸与纳米氧化锌抑菌组合物 | |
CN116570557A (zh) | 一种兽用药品—山苍籽油口服液的处方及制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Dingkuo Inventor after: Tao Rong Inventor after: Wang Lihong Inventor after: Zhao Yunying Inventor after: Zhao Jingjing Inventor after: Zhang Junxia Inventor before: Liu Dingkuo Inventor before: Wang Lihong Inventor before: Zhao Yunying Inventor before: Zhao Jingjing Inventor before: Zhang Junxia |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200702 Address after: Unit 516, block a, No. 3, Huatian Road, Huayuan Industrial Zone, Binhai New Area, Tianjin Patentee after: Tianjin aotailai Biotechnology Co.,Ltd. Address before: 300402, No. 1, Jing Yuan Road, Beichen Science Park, Jin Wai highway, Beichen District, Tianjin Patentee before: S&E ANIMAL PHARMACEUTICAL (TIANJIN) Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240516 Address after: Room C101-2, Conference Building, Tianjin International Biomedical Joint Research Institute, No. 220 Dongting Road, Economic and Technological Development Zone, Binhai New Area, Tianjin, 300000 Patentee after: Tianjin United Chuangyan Biomedical Technology Co.,Ltd. Country or region after: China Address before: 300392 unit 516, area a, complex building, No.3, Huatian Road, Huayuan Industrial Zone, Binhai New Area, Tianjin Patentee before: Tianjin aotailai Biotechnology Co.,Ltd. Country or region before: China |